Cleared Traditional

K802521 - CK-MB(IMMUNOLOGICAL)

K802521 is an FDA 510(k) clearance for CK-MB(IMMUNOLOGICAL), manufactured by Biodynamics Corp.. The device is a Class 2 Hematology device with product code JHS cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K802521 · Biodynamics Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1980
Decision
28d
Days
Class 2
Risk

K802521 is an FDA 510(k) clearance for the CK-MB(IMMUNOLOGICAL). Classified as Differential Rate Kinetic Method, Cpk Or Isoenzymes (product code JHS), Class II - Special Controls.

Submitted by Biodynamics Corp. (Walker, US). The FDA issued a Cleared decision on November 12, 1980 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1215 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biodynamics Corp. devices

FDA 510(k) Submission Details - K802521

510(k) Number K802521 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 1980
Decision Date November 12, 1980
Days to Decision 28 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 113d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHS Device Classification - Class 2, Special Controls

Product Code JHS Differential Rate Kinetic Method, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JHS Differential Rate Kinetic Method, Cpk Or Isoenzymes

All 33
Devices cleared under the same product code (JHS) and FDA review panel - the closest regulatory comparables to K802521.
CPK(CK) IN VITRO DIAG. REAGENT SET
K813406 · Pointe Scientific, Inc., · Dec 1981
WORTHINGTON CK (NAC) REAGENT SET
K810997 · Worthington Diagnostic Systems · Apr 1981
CARDIOZYME PLUS CK-TOTAL #65046
K803169 · Harleco · Jan 1981
WORTHINGTON FLOZYME* CPK (340NM)
K800028 · Worthington Diagnostic Systems · Jan 1980
ESKACHEM, CK-MB REAGENT
K792023 · Smithkline Diagnostics, Inc. · Oct 1979
CK-NUC REAGENT
K790916 · Smithkline Diagnostics, Inc. · Jun 1979